Tolerability, pharmacokinetic and pharmacodynamic assessment of teriparatide nasal spray versus subcutaneous teriparatide in postmenopausal female volunteers.

Trial Profile

Tolerability, pharmacokinetic and pharmacodynamic assessment of teriparatide nasal spray versus subcutaneous teriparatide in postmenopausal female volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Oct 2010

At a glance

  • Drugs Teriparatide; Teriparatide
  • Indications Osteoporosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 19 Oct 2010 Status changed from recruiting to completed.
    • 19 Oct 2010 Results presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research
    • 19 Oct 2010 Study title not official.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top